|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1993-7-13
|
|
pubmed:abstractText |
To reduce the side effects of cisplatin-based combination chemotherapy, the activity of carboplatinum was evaluated in patients with advanced seminoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
237-43
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8508413-Adult,
pubmed-meshheading:8508413-Aged,
pubmed-meshheading:8508413-Carboplatin,
pubmed-meshheading:8508413-Dysgerminoma,
pubmed-meshheading:8508413-Follow-Up Studies,
pubmed-meshheading:8508413-Humans,
pubmed-meshheading:8508413-Lymphatic Metastasis,
pubmed-meshheading:8508413-Male,
pubmed-meshheading:8508413-Middle Aged,
pubmed-meshheading:8508413-Neoplasm Recurrence, Local,
pubmed-meshheading:8508413-Prognosis,
pubmed-meshheading:8508413-Remission Induction,
pubmed-meshheading:8508413-Salvage Therapy
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Single-agent carboplatinum for advanced seminoma. A phase II study.
|
|
pubmed:affiliation |
Department of Hematology/Oncology, Hannover University Medical School, Federal Republic of Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
